Quantification of red blood cell fragmentation by automated haematology analyser XE-2100

被引:31
作者
Jiang, MY
Saigo, K
Kumagai, S
Imoto, S
Kosaka, Y
Matsumoto, H
Fujimoto, K
机构
[1] Sysmex Corp, Div Sci, Nishi Ku, Kobe, Hyogo 6512271, Japan
[2] Kobe Univ Hosp, Blood Transfus Div, Kobe, Hyogo, Japan
[3] Hyogo Med Ctr Adults, Dept Med, Div Hematol Oncol, Akashi, Hyogo, Japan
[4] Kobe Univ, Sch Med, Dept Pediat, Kobe, Hyogo 650, Japan
[5] Sysmex Corp, Sci Instrumentat Div, Kobe, Hyogo, Japan
来源
CLINICAL AND LABORATORY HAEMATOLOGY | 2001年 / 23卷 / 03期
关键词
red blood cell fragmentation; quantification; flow cytometry; XE-2100; validity;
D O I
10.1046/j.1365-2257.2001.00386.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The extent of red blood cell fragmentation in peripheral blood is useful for diagnosis and follow-up in many diseases, e.g. haemolytic uremic syndrome, transplantation-associated thrombotic microangiopathy (BMT-TMA). However, this quantification still relies on manual counting of fragmented red cells on blood smears. We have developed a quantification system by gating a fixed area of fragmented red blood cells (Gate 1) on an automated haematology analyser (XE-2100, Sysmex Co., Kobe, Japan). The fragmented red cell percentage (FRC%) calculated with this system, from 100 samples, was highly correlated with the manual count (r = 0.902, P < 0.0001). Because microcytic anaemia specimens usually occupy a lower position on the XE-2100 scattergram, with microcytic cells overlapping Gate I and causing a spuriously high FRC% calculation, a supplementary gate (Gate 2) was added. Using the particle number in this gate as well as in Gate 1, a revised method for such samples was developed and its validity confirmed (revised FRC% correlated with a manual count for 10 subjects (P < 0.001). Because this gating system can be programmed on any XE-2100, it is likely to prove useful for accurate quantification of red blood cell fragmentation and for the monitoring of the development of BMT-TMA.
引用
收藏
页码:167 / 172
页数:6
相关论文
共 16 条
[1]   RED BLOOD-CELL FRAGMENTATION - IMPROVED DETECTION AND IDENTIFICATION OF CAUSES [J].
BESSMAN, JD .
AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 1988, 90 (03) :268-273
[2]  
BULL BS, 1975, BLOOD, V45, P581
[3]  
Dacie SJ, 1984, PRACTICAL HAEMATOLOG, P68
[4]  
GUETARNI D, 1992, ANN BIOL CLIN-PARIS, V50, P649
[5]  
HOLLER E, 1989, BLOOD, V73, P2018
[6]   Severe thrombotic microangiopathy: an infrequent complication of bone marrow transplantation [J].
Iacopino, P ;
Pucci, G ;
Arcese, W ;
Bosi, A ;
Falda, M ;
Locatelli, F ;
Marenco, P ;
Miniero, R ;
Morabito, F ;
Rossetti, F ;
Sica, S ;
Uderzo, C ;
Bacigalupo, A .
BONE MARROW TRANSPLANTATION, 1999, 24 (01) :47-51
[7]   MICROANGIOPATHY FOLLOWING ALLOGENEIC MARROW TRANSPLANTATION - ASSOCIATION WITH CYCLOSPORINE AND METHYLPREDNISOLONE FOR GRAFT-VERSUS-HOST DISEASE PROPHYLAXIS [J].
KALHS, P ;
BRUGGER, S ;
SCHWARZINGER, I ;
GREINIX, HT ;
KEIL, F ;
KYRLE, PA ;
KNOBL, P ;
SCHNEIDER, B ;
HOCKER, P ;
LINKESCH, W ;
LECHNER, K .
TRANSPLANTATION, 1995, 60 (09) :949-957
[8]  
PALEK J, 1990, SEMIN HEMATOL, V27, P290
[9]  
PETTITT AR, 1994, BONE MARROW TRANSPL, V14, P495
[10]   Thrombotic microangiopathy following allogeneic bone marrow transplantation [J].
Takatsuka, H ;
Takemoto, Y ;
Okamoto, T ;
Fujimori, Y ;
Tamura, S ;
Wada, H ;
Okada, M ;
Kanamaru, A ;
Kakishita, E .
BONE MARROW TRANSPLANTATION, 1999, 24 (03) :303-306